Absolute Investment Advisers LLC Purchases Shares of 35,755 abrdn Life Sciences Investors $HQL

Absolute Investment Advisers LLC purchased a new position in shares of abrdn Life Sciences Investors (NYSE:HQL) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 35,755 shares of the company’s stock, valued at approximately $582,000.

Other institutional investors and hedge funds have also modified their holdings of the company. LPL Financial LLC boosted its stake in shares of abrdn Life Sciences Investors by 20.0% in the fourth quarter. LPL Financial LLC now owns 448,846 shares of the company’s stock worth $7,532,000 after buying an additional 74,787 shares during the last quarter. Landscape Capital Management L.L.C. purchased a new position in abrdn Life Sciences Investors during the fourth quarter valued at approximately $1,158,000. Raymond James Financial Inc. raised its position in abrdn Life Sciences Investors by 20.3% during the second quarter. Raymond James Financial Inc. now owns 375,960 shares of the company’s stock valued at $4,816,000 after acquiring an additional 63,429 shares in the last quarter. Formidable Asset Management LLC lifted its holdings in abrdn Life Sciences Investors by 63.3% in the fourth quarter. Formidable Asset Management LLC now owns 124,445 shares of the company’s stock valued at $1,930,000 after acquiring an additional 48,252 shares during the period. Finally, Ameriprise Financial Inc. lifted its holdings in abrdn Life Sciences Investors by 24.5% in the third quarter. Ameriprise Financial Inc. now owns 209,681 shares of the company’s stock valued at $3,254,000 after acquiring an additional 41,255 shares during the period. Institutional investors and hedge funds own 32.21% of the company’s stock.

abrdn Life Sciences Investors Stock Performance

abrdn Life Sciences Investors stock opened at $19.32 on Monday. abrdn Life Sciences Investors has a 12 month low of $12.71 and a 12 month high of $19.40. The stock’s 50 day simple moving average is $17.67 and its two-hundred day simple moving average is $17.12.

abrdn Life Sciences Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Thursday, May 21st will be paid a $0.56 dividend. This represents a $2.24 annualized dividend and a dividend yield of 11.6%. The ex-dividend date is Thursday, May 21st.

abrdn Life Sciences Investors Company Profile

abrdn Life Sciences Investors (NYSE: HQL) is a closed-end management investment company that seeks capital appreciation through investment in the life sciences sector. Established in 1994, the trust focuses on equity and equity-related securities of companies engaged in biotechnology, pharmaceuticals, medical devices, diagnostics and related fields. Its closed-end structure allows portfolio managers to maintain a stable pool of capital, pursue long-term investment strategies and employ leverage when deemed appropriate.

The fund’s portfolio spans both public and private companies, with an emphasis on businesses driving innovation in drug development, gene therapy, precision medicine and healthcare technology.